1 |
Almeida, S., Filipe, A., Almeida, A., Gich, I., Antonijoan, R., Puntes, M., Barbanoj, M. and Caturla, M. C. 2006. Comparative study on the bioequivalence of two formulations of pravastatin. Arzneimittelforschung 56, 70-75.
|
2 |
Bharate, S. S., Bharate, S. B. and Bajaj, A. N. 2010. Interactions and incompatibilities of pharmaceutical excipients with active pharmaceutical ingredients: a comprehensive review. J. Excip. Food Chem. 1, 3-26.
|
3 |
Brain-isasi, S., Requena, C. and Alvarez-lueje, A. 2008. Stability study of pravastatin under hydrolytic conditions assessed by HPLC. J. Chil. Chem. Soc. 53, 1684-1688.
|
4 |
Drug-excipient compatibility studies. 2014. http://pharmaquest.weebly.com/uploads/9/9/4/2/9942916/drug_excipient_compatibility_study.pdf
|
5 |
Gao, J., Fu, X., Ding, M. and Fu, Q. 2010. Studies on partial compatibility of PP and PS. Chin. J. Polym. Sci. 28, 647-656.
DOI
|
6 |
Hirano, T., Komuro, F., Furukawa, S., Nagano, S. and Takahashi, T. 1990. Effect of pravastatin sodium, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on very-low-density lipoprotein composition and kinetics in hyperlipidemia associated with experimental nephrosis. Metabolism 39, 605-609.
DOI
|
7 |
International Conference on Harmonisation (ICH) guideline. 2009. Pharmaceutical development Q8 (R2). Step 5 versions.
|
8 |
Jeong, Y. J., Kim, J. M., Jang, S. J., Bang, J. H., Jung, Y. G., Kim, S. T., Kang, S. H., Choi, J. I., Kim, S. S. and Kang, M. Y. 2017. The effect of pravastatin on insulin resistance in hyperglycemic patients. J. Kor. Diabetes 18, 53-61.
DOI
|
9 |
Kivisto, K. T., Grisk, O., Hofmann, U., Meissner, K., Moritz, K. U., Ritter, C., Arnold, K. A., Lutjoohann, D., von Bergmann, K., Kloting, I., Eichelbaum, M. and Kroemer, H. K. 2005. Disposition of oral and intravenous pravastatin in MRP2-deficient TR- rats. Drug Metab. Dispos. 33, 1593-1596.
DOI
|
10 |
Kim, K. M. and Kang, J. S. 2017. Design of experiments for coating process of valsartan and pravastatin fixed-dose combination tablet. Indian J. Pharm. Educ. 51, 128-135.
DOI
|
11 |
Malgorzata, P., Mohamed, S., Polonca, T. and Drago, K. 2010. Stability studies of cholesterol lowering statin drugs in aqueous samples using HPLC and LC-MS. Environ. Chem. Lett. 8 185-191.
DOI
|
12 |
Marian, E., Jurca, T., Kacso, I., Borodi, G., Rus, L. M. and Bratu, I. 2015. Compatibility study between simvastatin and excipients in their physical mixtures. Rev. Chim. 66, 803-807.
|
13 |
Ministry of Food and Drug Safety. 2015. http://www.mfds.go.kr/index.do?cd=&searchkey=title:contents&mid=914&pageNo=6&seq=22056&cmd=v
|
14 |
U.S. Pharmacopeia 31-NF 26, second supplement. 2008. http://www.uspnf.com/uspnf/pub/index?usp=31&nf=26&s=1
|
15 |
Ministry of Food and Drug Safety. Korean pharmacopoeia 11th. Notification No. 2017-63.
|
16 |
Rowe, R. C., Sheskey, P. J. and Owen, S. C. 2006. Handbook of pharmaceutical excipients. 5th ed. Pharmaceutical press, London, UK.
|
17 |
Sohn, Y. T. and Lee, A. K. 1999. Compatibility study using differential scanning calorimetry. J. Kor. Pharm. Sci. 29, 117-126.
|
18 |
U.S. Pharmacopeia 38-NF 33, 2015. The United States Pharmacopoeia, Rockville, MD: United States Pharmacopoeial Convention Inc., pp. 4966-4967.
|